James “Jamie” Levine has joined Primordial Genetics’ Board of Directors, bringing deep executive experience in industrial biotechnology and finance to the company’s leadership. Mr. Levine is CEO and a member of the Board of Directors of Annai Systems, a private a leading genomic data analysis company, and CEO and a member of the Board of Directors of Sapphire Energy, a private company creating human nutraceutical products from outdoor algae cultivation. Previously Mr. Levine was CEO at Verenium Corporation, a NASDAQ-Listed company that developed enzyme products for diverse end-markets including animal feed. Verenium was acquired by the chemical company BASF in 2013. Prior to joining Verenium, Mr. Levine was a Managing Director in the investment banking department of Goldman Sachs & Co. where he served clients in the Healthcare and Energy industries. Mr. Levine received an MBA degree from the Wharton School of the University of Pennsylvania and a BA from Brandeis University.
Home » posts » James E. Levine joins Primordial Genetics’ Board of Directors
“Utilizing the Human Genome to Expand Microbial Potential with Primordial Genomics,” Covered by DNA Weekly
Team PrimordialAugust 4, 2022
Primordial Genetics Receives $55K I-Corps™ at NIH Grant for Enzymatic DNA Synthesis Market Survey
Team PrimordialApril 29, 2021
Primordial Genetics Awarded $1.15M Grant from the National Institute of General Medical Sciences for Revolutionary Ways to Manufacture Therapeutics and Vaccines
Team PrimordialAugust 6, 2020